Biotechnology
Sort by: Featured Most recent Most read Most commented
62 results total, viewing 1 - 10
Mass. biotech firms look to prepare vets for openings to come
A group of human resource executives from five Massachusetts biotechnology companies gathered Tuesday to brainstorm how to better prepare military veterans for jobs in the sector, according to the Boston Business Journal. more
| 5/15/13
Jewelry designer, tennis online booking service, 3D printing marketplace win Business Plan
The 2013 edition of the Rhode Island Business Plan Competition announced its winners Tuesday afternoon at The Garage, the Greater Providence Chamber of Commerce’s exposition dedicated to identifying and inspiring high-growth companies in the Ocean State. more
| 5/14/13
Amgen drugs may boost survival after a nuclear attack
Amgen Inc.’s Neulasta and Neupogen and a similar blood-boosting drug from Teva Pharmaceutical Industries Ltd. may help people survive after a nuclear attack, U.S. regulators said. more
Covidien’s profits drop in 2Q as sales rise 5%
Medical technology maker Covidien Plc reported second-quarter earnings of $439 million, or 92 cents per diluted share, an 11.7 percent drop from the $497 million, or $1.02 per diluted share, it reported during the second quarter of 2012. more
| 4/26/13
Amgen tops analyst estimates as profit benefits from tax credit
Amgen Inc., which has a production facility in West Greenwich, reported first-quarter profit that beat analyst estimates because of a research tax credit. more
EpiVax, partners move ahead on H7N9 flu vaccine production
New recipes for a vaccine to combat the H7N9 flu went into production this weekend, in a collaboration between EpiVax and Aldevron in Fargo, N.D., and a researcher at Fort Detrick, Md., the home of the Army Medical Research Institute of Infectious Diseases, according to Dr. Anne S. De Groot. more
IlluminOss taps Kuyper as president and CEO
IlluminOss Medical Inc. has named Dirk M. Kuyper its new president and CEO effective Monday. Kuyper is taking over for Scott Rader, whose position with the company ended in late October, the company announced Tuesday. more
| 4/9/13
EpiVax creates recipe for novel vaccine approach to new flu strain
An analysis of the new strain of what’s being called Shanghai bird flu, conducted by Dr. Anne S. De Groot and her team of researchers at EpiVax Inc., has concluded that there may be the need to develop a new vaccine to combat a potential devastating outbreak of the disease. more
Brown profs. attend White House brain initiative announcement
When President Obama announced his new $100 million Brain Research through Advancing Innovative Neurotechnologies initiative from the East Room at the White House on April 2, two Brown University professors, who had helped to plan this sweeping new vision for brain research, attended the ceremony. more
Alexion gets FDA warning over contamination at R.I. plant
Alexion Pharmaceuticals was hit with a warning letter from the U.S. Food and Drug Administration over its investigation of bacterial contamination at its Rhode Island facility, reported MarketWatch’s Health Exchange blog. more
| 4/1/13
1 | 2 | 3 | 4 | 5 | 6 | 7 Next »
Calendar
PBN Hosted
Events

Celebrate RI's many exceptional women at PBN's Business Women Awards luncheon May 30th at the Providence Marriott. Reserve your seat today!
Advertisement
National
Local
Latest News